CSIMarket
 


Amag Pharmaceuticals inc   (AMAG)
Other Ticker:  
 
 

AMAG's Income from Cont. Operations Growth by Quarter and Year

Amag Pharmaceuticals Inc 's Income from Cont. Operations results by quarter and year




AMAG Income from Cont. Operations (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -201.13 -24.60 3.50
III Quarter September 19.35 -23.62 -64.68 -152.06
II Quarter June 0.16 -120.83 -25.82 -14.07
I Quarter March -0.10 -122.08 -54.24 -36.60
FY   19.41 -467.66 -169.34 -199.23



AMAG Income from Cont. Operations third quarter 2020 Y/Y Growth Comment
Amag Pharmaceuticals inc in the third quarter 2020 achieved Income from Cont. Operations of $ 19.35 millions compare to loss from continued operations recorded in same quarter a year ago.

According to the results reported in the third quarter 2020, Amag Pharmaceuticals Inc achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Amag Pharmaceuticals Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. 4 in the third quarter 2020.




AMAG Income from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Amag Pharmaceuticals Inc 's third quarter 2020 Income from Cont. Operations $ 19.35 millions AMAG's Income Statement
Amag Pharmaceuticals Inc 's third quarter 2019 Income from Cont. Operations $ -23.62 millions Quarterly AMAG's Income Statement
New: More AMAG's historic Income from Cont. Operations Growth >>


AMAG Income from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September 11994.38 % - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #2
Overall #4

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
11994.38 % 5442.41 % -90.98 %
(Sep 30 2020)   (Mar 31 2015)
Income from Cont. Operations third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #2
Overall #4
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
11994.38 % 5442.41 % -90.98 %
(Sep 30 2020)   (Mar 31 2015)

Income from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Amag Pharmaceuticals Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
11994.38 % 5442.41 % -90.98 %
(Sep 30 2020)  


AMAG's III. Quarter Q/Q Income from Cont. Operations Comment
Amag Pharmaceuticals inc achieved in the III. Quarter 2020 above company average sequential Income from Cont. Operations doubling of 11994.38%, to $ 19.35 millions, from $0.16 millions in the second quarter.
Major Pharmaceutical Preparations company is going from strength to strength, with reporting better then regular growth, and also increasing speed.

Within Major Pharmaceutical Preparations industry Amag Pharmaceuticals inc achieved highest sequential Income from Cont. Operations growth. While Amag Pharmaceuticals Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 4.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #2
Overall #4
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #2
Overall #4
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
11994.38 % 5442.41 % -90.98 %
(Sep 30 2020)  


AMAG's III. Quarter Q/Q Income from Cont. Operations Comment
Amag Pharmaceuticals inc achieved in the III. Quarter 2020 above company average sequential Income from Cont. Operations doubling of 11994.38%, to $ 19.35 millions, from $0.16 millions in the second quarter.
AMAG is undergoing a remarkable growth, not only reporting better then average gain, and also accelerating rate, Sean Thompson, market researcher located in Seattle mentioned.

Within Major Pharmaceutical Preparations industry Amag Pharmaceuticals inc achieved highest sequential Income from Cont. Operations growth. While Amag Pharmaceuticals Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 4.


Amag Pharmaceuticals Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative Income from Cont. Operations 12 Months Ending $ -181.72 $ -224.69 $ -345.68 $ -467.66 $ -291.13
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment


Amag Pharmaceuticals inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment


Amag Pharmaceuticals inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
AMAG's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for AMAG's Competitors
Income from Cont. Operations Growth for Amag Pharmaceuticals Inc 's Suppliers
Income from Cont. Operations Growth for AMAG's Customers

You may also want to know
AMAG's Annual Growth Rates AMAG's Profitability Ratios AMAG's Asset Turnover Ratio AMAG's Dividend Growth
AMAG's Roe AMAG's Valuation Ratios AMAG's Financial Strength Ratios AMAG's Dividend Payout Ratio
AMAG's Roa AMAG's Inventory Turnover Ratio AMAG's Growth Rates AMAG's Dividend Comparisons



Companies with similar Income from Cont. Operations doubling for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2020
Tenax Therapeutics Inc -0.15%$ -0.147 millions
Tactile Systems Technology Inc -0.29%$ -0.288 millions
Conmed Corporation-1.72%$ -1.722 millions
Mylan N v -2.16%$ -2.160 millions
Eli Lilly And Company-3.63%$ -3.629 millions
Baxter International Inc -4.27%$ -4.267 millions
Viemed Healthcare Inc -5.27%$ -5.270 millions
Icu Medical Inc-5.94%$ -5.937 millions
Emergent Biosolutions Inc -8.56%$ -8.565 millions
Bruker Corporation-10.08%$ -10.081 millions
3m Company-10.77%$ -10.768 millions
Innoviva Inc -11.54%$ -11.541 millions
Acadia Healthcare Company Inc -12.08%$ -12.082 millions
Biospecifics Technologies Corp-14.13%$ -14.129 millions
China Health Industries Holdings Inc -15.45%$ -15.449 millions
Encompass Health Corporation-16.23%$ -16.234 millions
Corcept Therapeutics Inc-17.90%$ -17.901 millions
Heartbeam Inc -18.94%$ -18.942 millions
Intuitive Surgical Inc -20.54%$ -20.542 millions
Utah Medical Products Inc-20.84%$ -20.837 millions
89bio Inc -22.01%$ -22.013 millions
Becton Dickinson And Company-22.09%$ -22.086 millions
Illumina Inc -23.50%$ -23.504 millions
Atrion Corporation-24.51%$ -24.513 millions
American Renal Associates Holdings Inc -24.90%$ -24.902 millions
Carlisle Companies Incorporated-26.56%$ -26.561 millions
Fonar Corporation-27.85%$ -27.852 millions
National Healthcare Corp-33.59%$ -33.588 millions
Msa Safety Incorporated-33.74%$ -33.740 millions
Zynex inc -34.43%$ -34.432 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com